Back to Search

Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, With Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

  • Protocol Number: 202206023
  • Principal Investigator: Abboud, Ramzi
  • Cancer Types: Leukemia, Myeloma, and Hematologic

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions